Stoke Therapeutics Cash Flow Statement (2018-2026) | STOK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-25.27M	-90.70M	-26.00M	-32.19M	-29.28M	-124.55M	-24.71M	-37.09M	-27.17M	-162.77M	-26.37M	-25.70M	-26.43M	-14.74M	112.88M	-23.48M	-38.35M	-62.44M	-50.00M	-61.62M
Depreciation and Depletion (Quarter)	0.25M	0.23M	0.25M	0.30M	0.39M	0.61M	0.60M	0.61M	0.64M	0.62M	0.56M	0.55M	0.54M	0.55M	0.48M	0.45M	0.44M	0.41M	0.44M	0.46M
Share-based Compensation (Quarter)	4.61M	4.69M	4.97M	6.16M	5.93M	5.84M	5.89M	6.76M	6.55M	6.06M	5.41M	7.43M	7.49M	7.17M	6.75M	36.10M	8.04M	9.81M	8.75M	83.10M
Deferred Taxes (Quarter)
Asset Writedowns and Impairment (Quarter)																	0.70M
Cash from Operations (Quarter)	-14.68M	-16.26M	32.49M	-19.93M	-22.06M	-22.37M	-21.36M	-21.80M	-17.26M	-20.65M	-24.57M	-17.48M	-21.61M	-23.19M	131.83M	-25.42M	-30.37M	-30.45M	-60.58M	-56.59M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.25M	0.23M	0.25M	0.30M	0.39M	0.61M	0.60M	0.61M	0.64M	0.62M	0.56M	0.55M	0.54M	0.55M	0.48M	0.45M	0.44M	0.41M	0.44M	0.46M
Change in Working Capital
Change in Receivables (Quarter)														-0.30M	1.32M			-3.31M	-1.49M	2.73M
Change in Accured Expenses (Quarter)	2.45M	3.60M	-3.44M	1.06M	-1.35M	0.20M	0.35M	-4.43M	2.02M	-1.15M	-1.92M	3.58M	-0.75M	2.18M	4.74M	2.77M	4.88M	8.90M	-15.72M	2.60M
Other Working Capital Changes (Quarter)	-0.23M	0.78M	3.27M	52.58M	-52.19M	48.08M	2.09M	-1.78M	0.51M	-4.17M	-2.42M	3.42M	-9.47M	-20.91M	1.23M	-1.84M	-4.06M	4.54M	3.59M	3.91M
Investing Activities
Capital Expenditures (Quarter)	0.27M	0.27M	0.84M	-0.09M	-0.35M	-0.28M	0.17M	0.84M	0.38M	0.23M	0.01M	0.05M	-0.05M	0.19M	0.03M	0.02M	0.04M	0.58M	0.35M	1.98M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)			9.00M	53.37M	79.00M	18.03M	53.25M	24.31M	15.00M	15.00M	10.00M		20.00M	30.00M	32.80M	33.23M	33.15M	37.40M	60.90M	47.10M
Cash from Investing Activities (Quarter)	-5.26M	11.80M	-135.78M	0.15M	67.26M	22.49M	53.09M	23.47M	14.62M	14.77M	9.99M	-88.28M	-30.00M	0.82M	13.63M	-148.48M	9.09M	-61.06M	50.69M	9.02M
Financing Activities
Other financing activities (Quarter)	0.43M	0.17M	0.09M	0.08M	0.28M	0.12M	0.15M	0.05M	0.16M	0.00M	0.25M	-0.08M	0.36M	1.19M	1.00M	-0.63M	0.63M	7.60M	3.21M	1.91M
Cash from Financing Activities (Quarter)	0.41M	0.17M	42.51M	3.42M	0.43M	0.04M	45.05M	0.05M	0.56M	7.34M	1.72M	120.65M	8.16M	0.57M	1.37M	0.55M	3.12M	92.34M	84.33M	1.91M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)	-19.54M	-4.29M	-60.78M	-16.36M	45.64M	0.16M	76.78M	1.72M	-2.08M	1.47M	-12.86M	14.89M	-43.46M	-21.81M	146.83M	-173.34M	-18.15M	0.83M	74.44M	-45.66M
Free Cash Flow (Quarter)	-14.96M	-16.53M	31.65M	-19.84M	-21.71M	-22.09M	-21.52M	-22.64M	-17.64M	-20.88M	-24.57M	-17.53M	-21.57M	-23.39M	131.80M	-25.45M	-30.41M	-31.03M	-60.94M	-58.56M
Net Cash Flow (Quarter)	-19.54M	-4.29M	-60.78M	-16.36M	45.64M	0.16M	76.78M	1.72M	-2.08M	1.47M	-12.86M	14.89M	-43.46M	-21.81M	146.83M	-173.34M	-18.15M	0.83M	74.44M	-45.66M

Research Tools

Datasets

Plans

Developers

Stoke Therapeutics Cash Flow Statement (2018-2026) | STOK

Research Tools

Datasets

Plans

Developers

Stoke Therapeutics Cash Flow Statement (2018-2026) | STOK

Create an account

Sign In

Reset Password